Australia markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.77-0.43 (-5.24%)
At close: 1:00PM EST
7.80 +0.03 (+0.39%)
After hours: 02:57PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
Total revenue
0
0
0
Operating expenses
Research development
79,772
68,604
47,927
Selling general and administrative
48,320
39,513
18,151
Total operating expenses
128,092
108,117
66,078
Operating income or loss
-128,092
-108,117
-66,078
Interest expense
-
0
625
Total other income/expenses net
-534
328
412
Income before tax
-128,626
-107,789
-66,291
Income tax expense
-518
-358
97
Income from continuing operations
-128,108
-107,431
-66,388
Net income
-128,108
-107,431
-66,388
Net income available to common shareholders
-128,108
-107,431
-66,388
Basic EPS
-
-1.22
-1.54
Diluted EPS
-
-1.22
-1.54
Basic average shares
-
87,757
43,199
Diluted average shares
-
87,757
43,199
EBITDA
-
-107,724
-65,645